Tumor-Infiltrating Lymphocytes and Programmed Cell Death - Ligand 1 in Breast Cancer

NCT05250336 · clinicaltrials.gov ↗

UNKNOWN

Status

1000

Enrollment

OTHER_GOV

Sponsor class

Conditions

Breast Cancer
Tumor Infiltrating Lymphocytes
Programmed Cell Death Ligand 1

Interventions

OTHER: Observational Study

Sponsor

Sanjay Gandhi Postgraduate Institute of Medical Sciences